| Outcome Measures: |
Primary: Mean Fasting Blood Glucose, The primary outcome of the study is to compare differences in mean fasting blood glucose levels between patients receiving insulin supplements at bedtime compared to those without insulin supplementation., up to 10 days | Secondary: Mean Daily BG, Secondary outcomes include differences between treatment groups in any of the following measures: mean daily BG, participants will be followed for the duration of hospital stay, an expected average of 6 days|Number of Hypoglycemia (BG < 70 mg/dl), Secondary outcomes include the number of hypoglycemia (BG \< 70 mg/dl) among both the groups., participants will be followed for the duration of hospital stay, an expected average of 6 days|Daily Dose of Insulin, Compare the daily dose of insulin used among both groups, participants will be followed for the duration of hospital stay, an expected average of 6 days|Length of Hospital Stay, Length of hospitalization, participants will be followed for the duration of hospital stay, an expected average of 6 days|Hospital Mortality, Mortality is defined as death occurring during admission or during the hospital stay, participants will be followed for the duration of hospital stay, an expected average of 6 days|Nosocomial Infections (CDC), Nosocomial infections during hospital stay as per the CDC criteria, participants will be followed for the duration of hospital stay, an expected average of 6 days|Pneumonia, Pneumonia (CDC criteria), participants will be followed for the duration of hospital stay, an expected average of 6 days|Bacteremia, Bacteremia with SIRS/Sepsis, participants will be followed for the duration of hospital stay, an expected average of 6 days|Participants Will be Followed for the Duration of Hospital Stay, an Expected Average of 6 Days, Respiratory failure, defined as PaO2 value \< 60 mm Hg while breathing air or a PaCO2 \> 50 mm Hg, daily while in hospital for up to 10 days|Acute Renal Failure [Rise >50% of Baseline or Creatinine >2.5 mg/dl], Acute renal failure \[rise \>50% of baseline or creatinine \>2.5 mg/dl\], participants will be followed for the duration of hospital stay, an expected average of 6 days|Number of BG Within Target, Number of glucose levels within target of 70-140 mg/dl, Participants will be followed over the hospital stay- expected 6 days.|Number of Subjects With BG > 300 mg/dL, Subjects will be followed over the hospital stay: expected 6 days
|
| Locations: |
Grady Memorial Hospital, Atlanta, Georgia, 30303, United States|Emory University Hospital, Atlanta, Georgia, 30322, United States
|
